Exor N.V.
EXXRF | OTC
$81.25
-$1.24 (-1.50%)
At close: Nov 5, 2026, 3:38 PM ET
$81.85
+$0.60 (+0.74%)
Pre-market:
Nov 5, 2026, 11:15 AM ET
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q4 2025 Dec 31, 2025 | Q2 2025 Jun 30, 2025 | Q4 2024 Dec 31, 2024 | Q2 2024 Jun 30, 2024 | Q4 2023 Dec 31, 2023 | Q2 2023 Jun 30, 2023 | Q4 2022 Dec 31, 2022 | Q2 2022 Jun 30, 2022 | Q4 2021 Dec 31, 2021 | Q2 2021 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | -4.11B | -3.59B | -302M | 15.4B | 38.52B | 44.74B | 44.53B | 41.84B | 36.16B | 33.62B | 28.25B |
Cost of Revenue | n/a | n/a | n/a | n/a | 17.59B | 33.43B | 33.85B | 32.34B | 28B | 25.98B | 21.07B |
Gross Profit | -4.11B | -3.59B | -302M | 15.4B | 20.93B | 11.31B | 10.68B | 9.51B | 8.16B | 7.64B | 7.18B |
Operating Income | -4.21B | -3.7B | -365M | 15.34B | 17.78B | 5.29B | 4.86B | 4.1B | 3.31B | 3.14B | 1.98B |
Interest Income | 58M | 58M | n/a | n/a | 16M | 1.68B | 2.58B | 1.94B | 1.03B | n/a | n/a |
Pretax Income | -4.2B | -3.7B | -572M | 14.76B | 18.5B | 7.87B | 7.32B | 5.9B | 4.93B | 4.65B | 3.5B |
Net Income | -4.29B | -3.79B | -648M | 14.67B | 16.73B | 4.19B | 3.7B | 1.81B | 777M | 1.35B | -847M |
Selling & General & Admin | 60M | 60M | 63M | 58M | 1.79B | 3.52B | 3.58B | 3.32B | 2.92B | 2.68B | 2.21B |
Research & Development | n/a | n/a | n/a | n/a | 1.33B | 2.47B | 2.24B | 2.09B | 2.19B | 2.08B | 2.99B |
Other Expenses | 44M | 44M | n/a | n/a | 13.5M | 8.5M | -5M | n/a | n/a | n/a | n/a |
Operating Expenses | 104M | 104M | 63M | 58M | 3.13B | 6B | 5.81B | 5.41B | 5.11B | 4.76B | 5.21B |
Interest Expense | 76M | 100M | 69M | 113M | 68M | n/a | n/a | n/a | 84.5M | 169M | 761.5M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -1.74B | -1.74B | n/a | n/a | 92.5M | 7M | -3.23B |
Cost & Expenses | 104M | 104M | 63M | 58M | 20.72B | 39.44B | 39.66B | 37.75B | 32.85B | 30.48B | 26.28B |
Income Tax Expense | 96M | 98M | 76M | 91M | 512M | 1.1B | 1.16B | 1.06B | 1.42B | 1.3B | 484M |
Shares Outstanding (Basic) | 202.4M | 207.63M | 207.63M | 210.57M | 219.36M | 225.58M | 230.15M | 234.66M | 231.85M | 209.35M | 231.36M |
Shares Outstanding (Diluted) | 202.4M | 207.63M | 207.63M | 214.11M | 219.36M | 225.58M | 230.15M | 234.66M | 231.85M | 209.35M | 231.36M |
EPS (Basic) | -20.80 | -18.26 | -3.11 | 66.89 | 76 | 18.38 | 15.94 | 12.24 | 8.12 | 7.20 | -2.84 |
EPS (Diluted) | -20.80 | -18.26 | -3.11 | 66.89 | 76.04 | 18.42 | 15.96 | 12.26 | 8.12 | 7.20 | -2.84 |
EBITDA | 582M | 582M | 1.24B | 17.39B | 19.9B | 7.34B | 5.98B | 5.15B | 4.28B | 4.06B | 5.02B |
EBIT | -515M | n/a | -365M | 15.34B | 17.78B | 5.29B | 4.88B | 4.11B | 3.32B | 3.15B | 3.33B |
Depreciation & Amortization | 1.1B | 582M | 1.61B | 2.05B | 2.12B | 2.05B | 1.11B | 1.04B | 961M | 904M | 1.68B |
Add to Watchlist
Select watchlists to add or remove EXXRF